Use of Infliximab for the Treatment of Pemphigus Vulgaris
Clinical trial NCT00283712 · COMPLETED
Trial details
- NCT number
- NCT00283712
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2010-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.